With an EC50 of only 22 nM against PrPSc accumulation in in PrPSc-infected mouse neuroblastoma (ScN2a-cl3) cells, compound 29 stood out among this series of derivatives and was found to be 100-fold more potent than the original lead compound. The gene discussed is SCN2A; the disease is neuroblastoma.